CN115487268B - Composition for promoting blood circulation and toxin metabolism and preparation method thereof - Google Patents
Composition for promoting blood circulation and toxin metabolism and preparation method thereof Download PDFInfo
- Publication number
- CN115487268B CN115487268B CN202211211323.6A CN202211211323A CN115487268B CN 115487268 B CN115487268 B CN 115487268B CN 202211211323 A CN202211211323 A CN 202211211323A CN 115487268 B CN115487268 B CN 115487268B
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- toxin
- blood
- blood circulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000017531 blood circulation Effects 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 230000001737 promoting effect Effects 0.000 title claims abstract description 21
- 230000028597 toxin metabolic process Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 238000002791 soaking Methods 0.000 claims abstract description 16
- 244000042430 Rhodiola rosea Species 0.000 claims abstract description 11
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract description 11
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 9
- 240000003915 Lophatherum gracile Species 0.000 claims abstract description 9
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 9
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 9
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 9
- 235000011477 liquorice Nutrition 0.000 claims abstract description 9
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 8
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 8
- 241000220317 Rosa Species 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract 2
- 241000196324 Embryophyta Species 0.000 claims description 29
- 239000004575 stone Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000004821 distillation Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000007605 air drying Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 244000183685 Citrus aurantium Species 0.000 claims description 3
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 3
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 3
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 2
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 47
- 210000004369 blood Anatomy 0.000 abstract description 47
- 239000003053 toxin Substances 0.000 abstract description 22
- 231100000765 toxin Toxicity 0.000 abstract description 22
- 238000001035 drying Methods 0.000 abstract description 7
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 238000009825 accumulation Methods 0.000 abstract description 3
- 241000218093 Phedimus aizoon Species 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 238000010025 steaming Methods 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 32
- 239000000686 essence Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- 230000036541 health Effects 0.000 description 22
- 108700012359 toxins Proteins 0.000 description 19
- 239000000463 material Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 230000004060 metabolic process Effects 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- 241000723353 Chrysanthemum Species 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 210000000744 eyelid Anatomy 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000011363 dried mixture Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000007410 oral glucose tolerance test Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010048222 Xerosis Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000004153 glucose metabolism Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- -1 iron ions Chemical class 0.000 description 2
- 239000010977 jade Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 239000010813 municipal solid waste Substances 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241001166076 Diapheromera femorata Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 208000004552 Lacunar Stroke Diseases 0.000 description 1
- 206010051078 Lacunar infarction Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010057469 Vascular stenosis Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052891 actinolite Inorganic materials 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000004634 pharmacological analysis method Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a composition for promoting blood circulation and toxin metabolism and a preparation method thereof, belonging to the technical field of traditional Chinese medicines; the composition comprises the following raw materials in parts by weight: 0.06 part of medicinal Wangshi, 6 parts of rhodiola rosea, 1.5-1.8 parts of sedum aizoon, 1.2-1.5 parts of liquorice, 1.8 parts of lophatherum gracile, 1.2-1.5 parts of lotus leaf, 0.9-1.5 parts of kudzuvine root, 0.9-1.2 parts of chrysanthemum, 1.5-1.8 parts of dried orange peel and 1.2-1.5 parts of rose; soaking the herbal composition for three times by adopting a three-steaming and three-soaking process, distilling for three times, and drying to obtain a finished product; the composition can promote the toxin deposited on the wall of the blood vessel to flow into the blood, and the toxin enters the intestinal tract along with the blood circulation and is discharged out of the body, so that the problem of toxin accumulation in the blood of the human body is solved.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and relates to a composition for promoting blood circulation and toxin metabolism and a preparation method thereof.
Background
In the current society, people have irregular diet, high life and study pressure, serious air pollution, excessive intake of garbage food, frequent stay up and the like, so that blood endotoxin cannot be metabolized in time, and the blood endotoxin becomes one of the main problems affecting human health, such as common hypertension, hyperlipidemia and hyperviscosity, which are diseases formed by the retention of typical blood toxins in the body. It is well known that fresh blood is a basic guarantee for maintaining human health, and when toxins stay in blood, not only some hematopathy is formed, but also the toxins have direct influence on viscera of a human body along with the circulation of blood. Modern medicine also proves that blood in the population suffering from three highs is relatively viscous, and toxins such as blood sugar, triglyceride, cholesterol and the like in the blood are retained in the body and cannot be metabolized in time. In addition, most modern people have vigorous deficiency fire, and the toxin in the body is corroded continuously, so that the normal metabolism of the human body is blocked. Because human daily metabolism can all produce new toxin, and in addition the toxin that has not in time been metabolized away before, blood endotoxin can pile up year by year, and this can directly lead to blood circulation speed to slow down on the one hand, aggravate the circumstances that metabolism is blocked on the other hand can cause the toxin to deposit on the vascular wall, and then arouse the vascular stenosis, if toxin piles up further to increase, can cause the blood vessel to block up in a certain part directly, appears more dangerous situation. More important, the current three-high problem (hypertension, hyperlipidemia and hyperviscosity) is younger year by year. Therefore, improving the blood metabolism ability in human blood, assisting the perennial precipitation of toxins which cannot flow freely on the blood vessel wall, metabolizing and discharging out of the body along with the blood circulation, is an urgent need for health in the present day.
The medicine king stone has the important effects of promoting blood circulation and expelling toxin on human health, and has the unique magnetic characteristics, good promoting effect on human blood circulation, high gain and activating effect on the medicine property of Chinese herbal medicine and inactive cells of human body. The medicine king stone, also called Tibetan jade, is a kind of dark green jade from the Tibetan forest glossy ganoderma area, and the treatment of diseases by the folk application medicine king stone in China has been 1700 years old, and the well-known ancient medical books of Shennong's herbal medicine channels, ben Cao gang mu and the like are recorded in detail. The medicine Wang Danzhong is rich in biotite, actinolite, calcite and active magnet, and contains various microelements such as calcium, magnesium, iron, zinc, selenium and the like beneficial to human body. The medicine king stone is combined with the activation of the traditional Chinese medicine and the inactive cells in blood, so that the herbal formula is developed in a targeted way, the blood circulation in blood vessels of a human body is smooth, the blood circulation speed is accelerated, the metabolism of blood toxins is further improved, and meanwhile, the blood environment of the human body is restored to an alkaline or alkalescent health state from acidity, so that the medicine king stone has positive influence on relieving or solving the blood problems of people at present.
Disclosure of Invention
The invention overcomes the defects of the prior art and provides a composition for promoting blood circulation and toxin metabolism and a preparation method thereof. So as to relieve the problem of human blood toxin accumulation.
In order to achieve the above purpose, the present invention is realized by the following technical scheme.
A composition for promoting blood circulation and toxin metabolism comprises the following raw materials in parts by weight: 0.06 part of medicinal Wangshi, 6 parts of rhodiola rosea, 1.5-1.8 parts of sedum aizoon, 1.2-1.5 parts of liquorice, 1.8 parts of lophatherum gracile, 1.2-1.5 parts of lotus leaf, 0.9-1.5 parts of kudzuvine root, 0.9-1.2 parts of chrysanthemum, 1.5-1.8 parts of dried orange peel and 1.2-1.5 parts of rose.
Preferably, the material comprises the following raw materials in parts by weight: 0.06 part of medicinal Wangshi, 6 parts of rhodiola rosea, 1.5 parts of seville orange flower, 1.2 parts of liquorice, 1.8 parts of lophatherum gracile, 1.2 parts of lotus leaf, 0.9 part of kudzuvine root, 0.9 part of chrysanthemum, 1.5 parts of dried orange peel and 1.2 parts of rose.
Preferably, the jobstone contains the following mineral components: al (Al) 2 O 3 ，BaO，CaO，Cr 2 O 3 ，TFe 2 O 3 ，K 2 O，MgO，MnO， Na 2 O，P 2 O 5 ，SiO 2 ，SO 3 ，SrO，TiO 2 。
A method of preparing a composition for promoting blood circulation and toxin metabolism comprising the steps of:
1) Soaking all the raw materials in water for 4-6 hours, and then dividing the raw materials into three parts;
2) Stirring and heating the three soaked raw materials to 85-90 ℃ respectively, and then distilling for 45-50 minutes to sequentially obtain a distillate A component, a distillate B component and a distillate C component; mixing A, B, C components, adding into plant residues obtained after distillation of the component C, and uniformly stirring;
3) Boiling the obtained plant residue mixed with the distillate to completely evaporate water to obtain a mixture;
4) Air drying the mixture, and oven drying at 50-60deg.C for 10-15min.
Preferably, the decoction is performed by adopting slow fire.
Preferably, the materials are dried by an oven and then ground into solid powder, and the solid powder is packaged.
The preparation method adopts a preparation process of three steaming and three soaking, and three parts of plant herbal essences are fused into one part of food material, so that the tonifying function of the medicinal royal jelly and the clearing and nourishing efficacy of the herbal are fused.
Pharmacological analysis:
the efficacy of the herbal medicines is as follows:
rhodiola rosea: has effects in invigorating qi, clearing away lung-heat, improving intelligence, nourishing heart, astringing, stopping bleeding, dispelling blood stasis, and relieving swelling;
substitution flower: has effects of dispersing stagnated liver qi, and relieving heart pressure;
licorice root: has effects of invigorating qi, invigorating spleen and stomach, improving spleen and stomach weakness, relieving fatigue, palpitation, and short breath;
lophatherum gracile: has effects in relieving dryness and restlessness, and treating upper region of heart fire;
lotus leaf: has effects of reducing blood lipid, loosening bowel to relieve constipation;
radix Puerariae: has effects in stabilizing blood sugar, stabilizing blood lipid and promoting metabolism;
and (3) chrysanthemum: has effects in lowering blood pressure, improving eyesight, and refreshing brain;
dried orange peel: has effects of regulating qi-flowing, invigorating spleen, eliminating dampness and eliminating phlegm;
and (3) rose: has effects of dispelling blood stasis, dredging collaterals, invigorating qi and replenishing blood;
medicinal Wangshi stone: contains a large amount of mineral elements required by human body, has high content of active magnet, and has health promotion effects of regulating physiological function and renal function of human body.
The principle of the formula is as follows:
in the formula of the invention, the monarch drugs are rhodiola rosea, seville orange flower and liquorice. The rhodiola rosea has high oxygen content, takes the effect of soothing liver and regulating qi by substituting flowers, has the effect of tonifying qi and supplementing middle-jiao by liquorice, supplements oxygen required by human body, and has the effects of improving oxygen content of human body by cooperation of the three, and promoting blood circulation by stimulating nerve circulation; the ministerial drugs of the formula are lophatherum gracile, lotus leaves, kudzuvine roots, chrysanthemum, dried orange peels and roses, which have the effects of activating blood and dissolving stasis, and can dissolve blood stasis in blood and enter a human toxin expelling channel along with blood circulation; the adjuvant drug of the formula is the medicinal royal stones, the magnetism of the medicinal royal stones enhances the property of the medicines in the herbal formula, on the one hand, inactive cells in a human body are activated, the absorption and metabolism capacity of the human body on the medicines are enhanced by the increase of the active cells, and under the activation of the medicinal royal stones, more active cells in the human blood are subjected to the action of a natural magnetic field to perform benign circulation, so that the blood circulation is smooth and stable, and the natural and healthy state is achieved.
The iron element of the active magnet in the medicine king stone has valence of +2 and +3, the iron element with valence of +2 loses electrons and oxidizes into iron with valence of +3, and the iron element with valence of +3 obtains electrons and reduces into iron with valence of +2, so the medicine king stone has electron obtaining capability and electron donating capability, and shows strong oxidation-reduction performance and electron transfer capability. After the medicine king stone enters a human body, electrons are lost through +2 valent iron ions to convert +3 valent iron ions, the lost electrons are transmitted to acidic substances in blood, the acidic substances are reduced to an alkaline state, the process that inactive cells are activated to active cells is completed, and the capability of the human body for absorbing herbal essence in the health preserving bag is improved. The active magnet in the medicinal royal jelly also has a gain effect on herbal essence, and the active ingredients of the Chinese herbal medicines are excited through charge transfer of the active magnet, so that the medicinal property is enhanced. Enhancing the property of herbal essence and improving the capability of human body to absorb the herbal essence, so that the absorption of nutrition and the metabolism of toxin by human body are enhanced. The rhodiola rosea, the medicinal royal stones and the herbal essence are matched for use, so that the activating effect of the medicinal royal stones is further enhanced, the oxygen content of cells is increased, the absorption of the herbal essence by the cells is promoted, the blood circulation is accelerated, and the metabolism of endotoxin rubbish in blood is promoted.
Compared with the prior art, the invention has the following beneficial effects:
(1) The invention selects natural herbal medicines for compatibility, does not contain any additive, is natural and green, is healthy and mild, and is synchronous in clearing and nourishing; (2) The medicine king stone component is added in the invention, and the medicine king stone component contains abundant mineral elements of human body, can promote toxin deposited on the vascular wall to flow into blood, and can discharge the toxin out of the body along with the blood circulation of the toxin entering the intestinal tract, thereby solving the problem of toxin accumulation of human body blood.
Detailed Description
In order to make the technical problems, technical schemes and beneficial effects to be solved more clear, the invention is further described in detail by combining the embodiments. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the invention. The following describes the technical scheme of the present invention in detail with reference to examples, but the scope of protection is not limited thereto.
Example 1
Wang Danshi combined health preserving bag with medicine for promoting blood circulation and toxin metabolism
1. Weighing three raw materials, wherein each raw material comprises 0.02g of medicinal royal stone, 2g of rhodiola rosea, 0.5g of substituted flowers, 0.4g of liquorice, 0.6g of lophatherum gracile, 0.4g of lotus leaves, 0.3g of kudzuvine root, 0.3g of chrysanthemum, 0.5g of dried orange peel and 0.4g of rose; the traditional Chinese medicine Wangshi is selected from the Tibetan area Yalu Tibetan river basin with extremely high collection difficulty and rare stock.
Taking one part of the raw materials for soaking for 4 hours;
2. distilling the soaked composition at high temperature, regulating the distillation temperature to 80 ℃, distilling at high temperature for 45 minutes, extracting plant essence, and pouring out plant residues;
3. taking a second part of raw materials, soaking for 4 hours, regulating the temperature to 80 ℃, continuously distilling at high temperature for 45 minutes, extracting plant essence, and pouring out plant residues;
4. taking a third part of raw materials, soaking for 4 hours, regulating the temperature to 80 ℃, distilling at a high temperature for 45 minutes, extracting plant essence, and keeping plant residues;
5. uniformly mixing the plant essence extracted by three times of distillation and the plant residue which remains, and decocting slowly with slow fire until the water is completely evaporated;
6. air-drying the evaporated mixture in a shade, and placing the air-dried mixture into a drying box for drying for 15 minutes at the temperature of 45 ℃; grinding the dried herbal mixture into solid powder, and bagging, wherein the weight of each bag is 6 g.
Example 2
Wang Danshi combined health preserving bag with medicine for promoting blood circulation and toxin metabolism
1. Weighing three raw materials, wherein each raw material comprises 0.02g of medicinal royal stone, 2g of rhodiola rosea, 0.6g of substituted flowers, 0.5g of liquorice, 0.6g of lophatherum gracile, 0.5g of lotus leaves, 0.4g of kudzuvine root, 0.4g of chrysanthemum, 0.6g of dried orange peel and 0.5g of rose, and taking one of the raw materials for soaking for 6 hours;
2. distilling the soaked composition at high temperature to 85 ℃, distilling at high temperature for 45 minutes, extracting plant essence, and pouring out plant residues;
3. taking a second part of raw materials, soaking for 6 hours, regulating the temperature to 85 ℃, continuously distilling at high temperature for 45 minutes, extracting plant essence, and pouring out plant residues;
4. taking a third part of raw materials, soaking for 6 hours, regulating the temperature to 85 ℃, distilling at a high temperature for 45 minutes, extracting plant essence, and keeping plant residues;
5. uniformly mixing the plant essence extracted by three times of distillation and the plant residue which remains, and decocting slowly with slow fire until the water is completely evaporated;
6. air-drying the evaporated mixture in a shade, and placing the air-dried mixture into a drying box for drying for 15 minutes at 50 ℃ under control; grinding the dried herbal mixture into solid powder, and bagging, wherein the weight of each bag is 6 g.
Example 3
The preparation method of the medicine Wang Danshi material combination health preserving bag for promoting blood circulation and toxin metabolism comprises the following steps:
1. weighing three raw materials, wherein each raw material comprises 0.03g of medicinal royal stone, 2g of rhodiola rosea, 0.6g of substituted flowers, 0.5g of liquorice, 0.6g of lophatherum gracile, 0.5g of lotus leaves, 0.3g of kudzuvine root, 0.5g of chrysanthemum, 0.5g of dried orange peel and 0.6g of rose; taking one part of the raw materials for soaking for 6 hours;
2. distilling the soaked composition at high temperature, controlling the distillation temperature to 90 ℃, distilling at high temperature for 50 minutes, extracting plant essence, and pouring out plant residues;
3. soaking the second raw material for 6 hours, regulating the temperature to 90 ℃, continuously distilling at high temperature for 50 minutes, extracting plant essence, and pouring out plant residues;
4. soaking the third raw material for 6 hours, regulating the temperature to 90 ℃, distilling at high temperature for 50 minutes, extracting plant essence, and keeping plant residues;
5. uniformly mixing the plant essence extracted by three times of distillation and the plant residue which remains, and decocting slowly with slow fire until the water is completely evaporated;
6. air-drying the evaporated mixture in a shade, and placing the air-dried mixture into a drying box for drying for 15 minutes at 50 ℃ under control; grinding the dried herbal mixture into solid powder, and bagging, wherein the weight of each bag is 6 g.
The administration method comprises the following steps: the herbal essence can be taken 1 time in the morning and afternoon each time, 2 bags each time are soaked in boiled water at 90-100 ℃ for 5-10 minutes and then taken, the soaking in boiled water is repeated for 3 times, and the herbal essence can be fully exerted after the soaking, so that the herbal essence has an effect for 1 week.
Test example:
the invention carries out an animal acute toxicity test, and the result shows that the invention has no obvious toxic reaction or other abnormality; the effect verification of blood glucose toxin metabolism is carried out, and the result shows that the invention can obviously promote the metabolism of blood glucose in blood.
1. Acute toxicity test of mice by intragastric administration
The purpose is as follows: three gavage dosing acute toxicity tests were performed with SPF grade kunming mice over 24 hours. The acute toxic reaction and death condition of the mice are observed, and experimental basis is provided for the safety of the mice.
The method comprises the following steps: mice were divided into 2 groups of 20 mice, and the three distilled herbal essences of example 3 of the present invention were administered by three times of gastric lavage at doses of 6g, 10g, 14g, 10 mice per group. After the animals are fasted and not forbidden for 12 hours, the corresponding test products are administrated by stomach irrigation for three times within 24 hours, the acute toxic reaction and death condition of the animals are observed, and then the animals are observed for 1 time every day and continuously observed for 14 days; weighing the body weight at 3 rd, 7 th and 14 th days of administration; animals were sacrificed until the end of 14d, and the animal organs were observed in a general anatomic manner, and the volume, color, texture, etc. of the organs were markedly abnormal.
Results: the mice are continuously observed for 4 hours after being subjected to gastric lavage, and no toxic reaction such as diarrhea, convulsion, hair erection, prone position and the like is found. Animals in the group of the invention do not die from the administration to the end of the test, the maximum administration amount of the mice by lavage is 30g, and the weights of the animals in the group of the invention are not obviously different from each other after the administration for 3, 7 and 14 days; after the test, the cervical dislocation is killed, the animal is roughly observed by naked eyes after dissection, and the volume, color, texture and the like of the organ tissues and organs of the animal are not abnormal.
Conclusion: under the test conditions, the maximum gastric lavage dosage of the mice provided by the invention is 36g, which is 6 times of the dosage of adults. After dissection, no obvious abnormality was found in the major viscera of the animals of the group of the invention.
2. Efficacy verification test of blood glucose metabolism in blood
Through an effect test of blood glucose metabolism in blood, the effect of the Wang Danshi material combination health preserving bag for promoting blood circulation and toxin metabolism, prepared in the above examples 1-3, is verified.
Inclusion criteria: age 30-70 years old, PG is more than or equal to 11.1mmol/L after 80g glucose is orally taken for 2 hours; the subject was informed and signed informed consent. Exclusion criteria: there are diseases caused by non-diabetes; women in gestation or lactation.
Test grouping and test method: a total of 80 persons (confirmed by hospitals as diabetics) are taken into the test, and are randomly and averagely divided into 4 groups, and 20 persons in each group (the average value of PG after oral administration of 80g of common sugar for 2 hours measured before the test is carried out is not significantly different among the groups); a first group took the medicine Wang Danshi material combination health preserving bag (2 times a day, 2 bags each) prepared in example 1; a second group took the medicine Wang Danshi material combination health preserving bag prepared in example 2 (2 times a day, 2 bags each); a third group took the medicine Wang Danshi material combination health preserving bag prepared in example 3 (2 times a day, 2 bags each); the fourth group was taken with metformin (500 mg each time, 1 time a day); the average value of each group before the start of the test was recorded and 1 time every 15 days was measured, and the test was continued for 2 months (data statistics were performed based on the average value of PG after 2 hours of oral administration of 80g of glucose, respectively).
The results of the OGTT test are shown in table 1 below:
TABLE 1
As shown in table 1, the OGTT can be maintained at a normal level within 2 months when the blood glucose in the blood is cleaned by adopting the medicine Wang Danshi material combination health preserving bag for promoting blood circulation and toxin metabolism; the Wang Danshi material combination health preserving bag prepared in the embodiment 1 has a remarkable and better treatment effect, can basically maintain the normal OGTT level in 1 month, and is beneficial to shortening the treatment course. The effect of the medicine Wang Danshi material combined health preserving bag for clearing blood sugar is also obviously superior to that of metformin.
The subjects were each given a periodic return visit (1 return visit per month, and a continuous return visit within 1 year) after the test was completed, and during the test and return visit, the administration of the drug Wang Danshi material combination health care package of examples 1-3 did not show significant adverse reactions, indicating that the safety of the drug Wang Danshi material combination health care package for promoting blood circulation and toxin metabolism of the present invention was good.
The foregoing description of the preferred embodiments of the invention is not intended to be limiting, but rather is intended to cover all modifications, equivalents, alternatives, and improvements that fall within the spirit and scope of the invention.
Typical cases:
(1) Case 1
Pay a certain woman, 50 years old. The obtained hypertension has high pressure of 160mmHg and low pressure of 100mmHg, and is usually dizziness, emaciation, weakness and weakness, and the traditional Chinese medicine diagnosis is yin-fluid deficiency and dryness-heat excess. The Wang Danshi material combined health preserving bag prepared by the invention is taken for 2 bags each time, 2 times a day, and divided into two courses of treatment, 1 month, and three courses of treatment. After the back consultation, the blood pressure is basically recovered to be normal, the high pressure is 130mmHg, the low pressure is 80mmHg, and the symptoms of dizziness and weakness are obviously relieved. According to the self-description of patients, the symptoms of the disease are reduced, and the spirit is good; after the administration, the patients continue to take the medicine for 6 courses of treatment for consolidation, so that the blood pressure is stable and no recurrence exists.
(2) Case 2
Some women, 68 years old. The obtained diabetes has the advantages of years of weakness, no force, urination, xerosis cutis, leg arterial thrombosis, edema, numbness, and fasting blood glucose value of 21-22mmol/L, and insulin is always injected for treatment. The Wang Danshi material combination health preserving bag prepared by the invention is taken for 2 times a day, and 1 month and one treatment course. After 3 courses of treatment, symptoms are relieved, leg edema disappears, insulin injection is not needed, and fasting blood glucose reaches 10-11mmol/L. And after the administration is continued for half a year, symptoms such as weakness, lack of strength, urination, xerosis cutis, leg artery thrombosis and the like are basically eliminated, and the blood sugar value is restored to 7-8 mmol/L. Until now blood sugar has been stable.
(3) Case 3
Luqi, male, 65 years old. Has cerebral infarction sequela, craniocerebral CT examination and diagnosis of bilateral basal ganglia lacunar infarction, severe headache and inability to sleep, the upper eyelid of the right eye is weak, the upper eyelid cannot be opened, one leg is weak, walking needs walking stick assistance, and the memory is poor. The Wang Danshi material combination health preserving bag prepared by the invention is taken for 2 bags each time, 1 day and 2 times, and is taken separately in the morning and afternoon for 1 month and one treatment course. After taking 3 courses of treatment, the headache is relieved, the sleep is improved, the upper eyelid of the right eye is half open, the legs are obviously powerful, and the memory is enhanced. After the administration is continued for half a year, the symptoms basically disappear, the sleep quality is good, the upper eyelid of the right eye is completely recovered, and the walking is separated from the crutch.
While the invention has been described in detail in connection with specific preferred embodiments thereof, it is not to be construed as limited thereto, but rather as a result of a simple deduction or substitution by a person having ordinary skill in the art to which the invention pertains without departing from the scope of the invention defined by the appended claims.
Claims (5)
1. The composition for promoting blood circulation and toxin metabolism is characterized by comprising the following raw materials in parts by weight: 0.06 part of medicinal Wangshi, 6 parts of rhodiola rosea, 1.5 parts of seville orange flower, 1.2 parts of liquorice, 1.8 parts of lophatherum gracile, 1.2 parts of lotus leaf, 0.9 part of kudzuvine root, 0.9 part of chrysanthemum, 1.5 parts of dried orange peel and 1.2 parts of rose.
2. A composition for promoting blood circulation and toxin metabolism according to claim 1, wherein the yaowan stone contains the following mineral components: al (Al) 2 O 3 ，BaO，CaO，Cr 2 O 3 ，TFe 2 O 3 ，K 2 O，MgO，MnO，Na 2 O，P 2 O 5 ，SiO 2 ，SO 3 ，SrO，TiO 2 。
3. A method for preparing a composition for promoting blood circulation and toxin metabolism according to claim 1 or 2, comprising the steps of:
1) Soaking all the raw materials in water for 4-6 hours, and then dividing the raw materials into three parts;
2) Stirring and heating the three soaked raw materials to 85-90 ℃ respectively, and then distilling for 45-50 minutes to sequentially obtain a distillate A component, a distillate B component and a distillate C component; mixing A, B, C components, adding into plant residues obtained after distillation of the component C, and uniformly stirring;
3) Boiling the obtained plant residue mixed with the distillate to completely evaporate water to obtain a mixture;
4) Air drying the mixture, and oven drying at 50-60deg.C for 10-15min.
4. The method of claim 3, wherein the decocting is performed with slow fire.
5. A method of preparing a composition for promoting blood circulation and toxin metabolism according to claim 3, wherein the composition is prepared by oven-drying and grinding into solid powder, and bagging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211211323.6A CN115487268B (en) | 2022-09-30 | 2022-09-30 | Composition for promoting blood circulation and toxin metabolism and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211211323.6A CN115487268B (en) | 2022-09-30 | 2022-09-30 | Composition for promoting blood circulation and toxin metabolism and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115487268A CN115487268A (en) | 2022-12-20 |
| CN115487268B true CN115487268B (en) | 2024-03-08 |
Family
ID=84471895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211211323.6A Active CN115487268B (en) | 2022-09-30 | 2022-09-30 | Composition for promoting blood circulation and toxin metabolism and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115487268B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116585395A (en) * | 2023-06-28 | 2023-08-15 | 南京同仁堂药业有限责任公司 | Traditional Chinese medicine composition and traditional Chinese medicine preparation for dispelling wind and relieving itching and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102451363A (en) * | 2010-10-28 | 2012-05-16 | 罗朝雯 | Chinese herbal medicinal weight-reducing tea |
| CN103110718A (en) * | 2013-02-03 | 2013-05-22 | 威海博力生物工程有限公司 | Preparation for regulating metabolism, protecting liver as well as preventing and treating cardiovascular and cerebrovascular diseases |
| CN106215012A (en) * | 2016-08-29 | 2016-12-14 | 广西康宝海美三高生态茶有限公司 | Prevention and treatment hypertension, hyperlipidemia, the teabag of hyperglycemia and processing method |
| CN107050349A (en) * | 2017-05-04 | 2017-08-18 | 南京苏新智慧社区服务有限公司 | A kind of cream taste of toxin expelling promoting blood circulation and its preparation method and application |
| CN108125091A (en) * | 2018-01-22 | 2018-06-08 | 斯汏克（北京）生物科技有限公司 | A kind of preparation method for improving cardiovascular and cerebrovascular Chinese herbal medicine composite enzyme drink |
-
2022
- 2022-09-30 CN CN202211211323.6A patent/CN115487268B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102451363A (en) * | 2010-10-28 | 2012-05-16 | 罗朝雯 | Chinese herbal medicinal weight-reducing tea |
| CN103110718A (en) * | 2013-02-03 | 2013-05-22 | 威海博力生物工程有限公司 | Preparation for regulating metabolism, protecting liver as well as preventing and treating cardiovascular and cerebrovascular diseases |
| CN106215012A (en) * | 2016-08-29 | 2016-12-14 | 广西康宝海美三高生态茶有限公司 | Prevention and treatment hypertension, hyperlipidemia, the teabag of hyperglycemia and processing method |
| CN107050349A (en) * | 2017-05-04 | 2017-08-18 | 南京苏新智慧社区服务有限公司 | A kind of cream taste of toxin expelling promoting blood circulation and its preparation method and application |
| CN108125091A (en) * | 2018-01-22 | 2018-06-08 | 斯汏克（北京）生物科技有限公司 | A kind of preparation method for improving cardiovascular and cerebrovascular Chinese herbal medicine composite enzyme drink |
Non-Patent Citations (1)
| Title |
|---|
| 脂糖泰胶囊降血糖实验研究;邢连喜;徐增康;蔺小平;常锋;刘建书;;陕西中医;-;第33卷(第12期);1685-1687 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115487268A (en) | 2022-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101797326B (en) | Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof | |
| CN103719494B (en) | A kind of great burdock achene defaecation health care tea for moistening intestines and preparation method thereof | |
| CN115487268B (en) | Composition for promoting blood circulation and toxin metabolism and preparation method thereof | |
| CN104815166B (en) | A kind of Chinese medicine composition for treating diabetes and its preparation and application | |
| CN109123351A (en) | A kind of special doctor's food and preparation method with hyperglycemia population generation meal regulatory function | |
| CN108619355A (en) | A kind of antitumor Chinese and preparation method thereof | |
| CN105056103A (en) | Steamed buns with assistant effect of reducing blood fat and cholesterol and processing method of steamed buns | |
| CN1660387A (en) | Health care preparation for regulating functional balance of organs of bowels in human body and preparing method | |
| CN110141619B (en) | Chinese herbal medicine composition for treating constipation and preparation method of gel patch thereof | |
| CN103520302A (en) | Sea-buckthorn leaf anti-fatigue capsule and preparation method thereof | |
| CN102614344B (en) | Traditional Chinese medicine for treating qi-blood deficiency periodontitis, preparation method and administration method thereof | |
| CN101991829B (en) | Medicament for treating stomach illness | |
| CN102671058B (en) | Traditional Chinese medicine oral liquid for treatment of vomiting and preparation method thereof | |
| CN101884760B (en) | Chinese medicinal composition for treating diabetes mellitus and preparation method thereof | |
| CN1242790C (en) | Composition for improving life quality of cancer patients | |
| CN108452160A (en) | A kind of ginseng stilbene Siberian cocklebur art preparation of breath in heptan training pancreas therapy treatment diabetes | |
| CN109200191A (en) | Restrain myogenic, Chinese materia medica preparation of light speckles, beautification and white and preparation method thereof | |
| CN106620397A (en) | Granules capable of preventing and treating dental ulcer and preparation method of granules | |
| RU2442595C2 (en) | Herbal complex for treatment of oncological diseases and method for treatment of digestive tract diseases using the said complex | |
| CN105267745A (en) | Traditional Chinese medicine composition for treating uremia and preparation method | |
| RU2133096C1 (en) | Biologically active food addition "pari" and method of its use | |
| CN104940777A (en) | Electuary capable of treating liver-yang hyperactivity and spleen weakness type diarrhea during menstruation and preparation method thereof | |
| CN104474440A (en) | Pharmaceutical composition for treatment of nutritional anemia of piglets and preparation method thereof | |
| CN104707030A (en) | Traditional Chinese medicine pills for treating esophageal cancer and preparation method thereof | |
| CN111956758A (en) | Pharmaceutical composition and preparation for treating recurrent oral ulcer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |